PHARMACY

K-V: FDA will approve Gestiva by PDUFA date

BY Alaric DeArment

ST. LOUIS — K-V Pharmaceutical announced Wednesday that the Food and Drug Administration extended its Prescription Drug User Fee Act action date to April 13 for a drug under development for preventing preterm birth.

K-V, which acquired the injected drug Gestiva (hydroxyprogesterone caproate) from Hologic in 2008, said Hologic originally had been told the FDA would take action Thursday.

K-V said it was confident the drug would receive approval and that the FDA would take action on or before the new PDUFA date.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

USciences, PGH develop sustainability training partnership

BY Allison Cerra

PHILADELPHIA and RESTON, Va. — University of the Sciences and Practice Greenhealth announced that they will collaborate to develop and promote sustainability training for pharmacists, pharmacy students and related professionals.

The USciences and PGH partnership includes:

  • Developing a methodology for assessing the effectiveness of sustainability training for pharmacists;

  • Assessing the feasibility of similar course offerings to pharmacy students at USciences; and

  • Encouraging collaborative and cooperative research activities that support the development of educational programs relating to pharmacists and sustainability.

"This collaboration will provide a great opportunity for leadership in sustainability education and research in pharmacy practice," said Lisa Lawson, dean of USciences’ Philadelphia College of Pharmacy. "With pharmacists already trusted members of the healthcare community, their involvement is key to providing environmental safeguards and safe medication handling."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

NCPA develops LTC advisory board

BY Allison Cerra

ALEXANDRIA, Va. — The National Community Pharmacists Association has created a new advisory board to help the organization’s push to expand long-term care pharmacy programming for its members.

The new group will play a key role in helping the NCPA to address the business impact of proposed government policy on independent pharmacy. Members include:

  • Jim McMackin of Wilson Pharmacy, Johnson City, Tenn.;

  • Dennis Conlin of Conlin’s Pharmacy, Methuen, Mass.;

  • Brian Beach of Kelley-Ross Pharmacy, Seattle;

  • Jim Dunham of Americare, Cookeville, Tenn.;

  • Stephen Carroll of All Care, Arkadelphia, Ark.;

  • Rick Steinhauser of Merwin LTC Pharmacy, Minneapolis;

  • Sharlea Leatherwood of Great Oak Pharmacy, Gladstone, Mo.;

  • Mike Flint of Mallatt Pharmacy, Madison, Wis.;

  • Michele Belcher of Grants Pass Pharmacy, Grants Pass, Ore.;

  • Ryan Beddingfield of United Pharmacy Services, Norcross, Ga.;

  • Russ Zakarian of Model Drug, Kingsburg, Calif.;

  • Paula Perrone of PerroneRx, Fort Worth, Texas;

  • Vernon Massengill of North Village Pharmacy, Yanceyville, N.C.;

  • Mary Ludlow of White Oak Pharmacy, Spartanburg, S.C.;

  • Patty Crawford of LTC Pharmacy Solutions, Richmond, Va.; and

  • Jeff Schneider of Legacy Consultant Pharmacy, Winston-Salem, N.C.

In related news, the NCPA announced that it had reformatted and improved its community-aging, assisted-living and long-term care program to include education opportunities for both beginning and seasoned practitioners.

“[The] NCPA is committed to meeting advocacy needs and providing business solutions to LTC pharmacies, and these are important steps toward that goal,” said Robert Greenwood, NCPA president. “The year 2011 will be filled with challenges and opportunities for LTC pharmacies, and NCPA will give independent long-term care pharmacy providers a strong, clear voice in their communities, Congress, the courts and in federal agencies.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES